NPRO 1100 Exam 1 Questions With Complete Solutions
therapeutic aPTT levels
1.5-3x normal value, 45-75 seconds
heparin administration
IV
enoxaparin drug type
anticoagulant
warfarin drug type
anticoagulant, vit K antagonist
to monitor during warfarin therapy
INR
INR measures
prothrombin time, coagulation
therapeutic INR value
2-3
warfarin antidote
vitamin k1
apixiban drug type
anticoagulant
apixiban administration
, oral
warfarin administration
oral or IV
supratherapeutic effects of anticoagulants
hemorrhage
subtherapeutic effects of anticoagulants
coagulation, thrombosis
virchow's triad
Stasis, hypercoagulability, vessel injury
vessel injury results
clotting, could form a thromboembolism
venous stasis results
slow blood causes blood clots
hypercoagability causes
coagulation, blood clots
dvt
deep vein thrombosis
dvt signs
redness, pain, swelling
dvt treatment
anticoagulants
therapeutic aPTT levels
1.5-3x normal value, 45-75 seconds
heparin administration
IV
enoxaparin drug type
anticoagulant
warfarin drug type
anticoagulant, vit K antagonist
to monitor during warfarin therapy
INR
INR measures
prothrombin time, coagulation
therapeutic INR value
2-3
warfarin antidote
vitamin k1
apixiban drug type
anticoagulant
apixiban administration
, oral
warfarin administration
oral or IV
supratherapeutic effects of anticoagulants
hemorrhage
subtherapeutic effects of anticoagulants
coagulation, thrombosis
virchow's triad
Stasis, hypercoagulability, vessel injury
vessel injury results
clotting, could form a thromboembolism
venous stasis results
slow blood causes blood clots
hypercoagability causes
coagulation, blood clots
dvt
deep vein thrombosis
dvt signs
redness, pain, swelling
dvt treatment
anticoagulants
